FdaApplication
NDA 017751
Identifiers
- fda_app_no: NDA017751
Properties
| Property | Value |
|---|---|
| applicant_name | ASTRAZENECA LP |
| application_type | NDA |
Products (5)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| DURANEST | ETIDOCAINE HYDROCHLORIDE | 0.5% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | INJECTABLE;INJECTION |
| DURANEST | ETIDOCAINE HYDROCHLORIDE | 1% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | INJECTABLE;INJECTION |
| DURANEST | EPINEPHRINE BITARTRATE; ETIDOCAINE HYDROCHLORIDE | 0.005MG/ML;1.5% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | INJECTABLE;INJECTION |
| DURANEST | EPINEPHRINE BITARTRATE; ETIDOCAINE HYDROCHLORIDE | 0.005MG/ML;1% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | INJECTABLE;INJECTION |
| DURANEST | EPINEPHRINE; ETIDOCAINE HYDROCHLORIDE | 0.005MG/ML;0.5% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | INJECTABLE;INJECTION |
5 products